TTE.US

60.24

+1.19%↑

EQNR.US

25.19

-0.16%↓

KMI

28.04

-0.71%↓

SLB

33.52

+1.92%↑

E

34.25

+1.06%↑

TTE.US

60.24

+1.19%↑

EQNR.US

25.19

-0.16%↓

KMI

28.04

-0.71%↓

SLB

33.52

+1.92%↑

E

34.25

+1.06%↑

TTE.US

60.24

+1.19%↑

EQNR.US

25.19

-0.16%↓

KMI

28.04

-0.71%↓

SLB

33.52

+1.92%↑

E

34.25

+1.06%↑

TTE.US

60.24

+1.19%↑

EQNR.US

25.19

-0.16%↓

KMI

28.04

-0.71%↓

SLB

33.52

+1.92%↑

E

34.25

+1.06%↑

TTE.US

60.24

+1.19%↑

EQNR.US

25.19

-0.16%↓

KMI

28.04

-0.71%↓

SLB

33.52

+1.92%↑

E

34.25

+1.06%↑

Search

Ultrapar Participacoes SA

Uždarymo kaina

SektoriusEnergijos sektorius

3.05 0.66

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

3.03

Max

3.09

Pagrindiniai rodikliai

By Trading Economics

Pajamos

-479M

363M

Pardavimai

-2.1B

33B

P/E

Sektoriaus vid.

8.472

35.126

Dividendų pajamingumas

4

Pelno marža

1.09

Darbuotojai

9,999

EBITDA

-5M

1.3B

Rekomendacijos

By TipRanks

Rekomendacijos

Neutralu

12 mėnesių prognozė

+20.92% upside

Dividendai

By Dow Jones

Dividendų pajamingumas

Sektoriaus vid.

4.00%

5.63%

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

158M

3.3B

Ankstesnė atidarymo kaina

2.39

Ankstesnė uždarymo kaina

3.05

Naujienos nuotaikos

By Acuity

40%

60%

49 / 145 reitingas Energy

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Strong Bearish Evidence

Ultrapar Participacoes SA Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2025-08-04 21:42; UTC

Uždarbis
Įsigijimai, susijungimai, perėmimai

Cabot to Acquire Mexico Carbon Manufacturing From Bridgestone

2025-08-04 21:21; UTC

Uždarbis
Pagrindinės rinkos jėgos

Vertex Stock Falls After Pain-Drug Setback, Despite Stronger 2Q Earnings -- Update

2025-08-04 20:45; UTC

Uždarbis

Vertex Pharmaceuticals Swings to 2Q Profit as Sales Climb

2025-08-04 19:15; UTC

Pagrindinės rinkos jėgos

TransMedics Group Shares Rise on FDA Approval for Clinical Trial

2025-08-04 23:41; UTC

Rinkos pokalbiai

Global Forex and Fixed Income Roundup: Market Talk

2025-08-04 23:41; UTC

Rinkos pokalbiai

Nikkei May Rise on Fed Stimulus Hopes

2025-08-04 23:28; UTC

Rinkos pokalbiai

Global Equities Roundup: Market Talk

2025-08-04 23:28; UTC

Rinkos pokalbiai

Gold Seen Stuck in Range as Investors Await Fed's Next Move -- Market Talk

2025-08-04 21:30; UTC

Uždarbis

Palantir Stock Jumps. Earnings Blew Past Wall Street's Expectations. -- Barrons.com

2025-08-04 21:21; UTC

Uždarbis
Įsigijimai, susijungimai, perėmimai

Berkshire Stock Was Hammered Monday. It's Like 1999 Again. -- Barrons.com

2025-08-04 21:18; UTC

Uždarbis

Palantir Stock Jumps. Earnings Blew Past Wall Street's Expectations. -- Barrons.com

2025-08-04 20:25; UTC

Rinkos pokalbiai

India Hits Back Over Russian Oil Purchases -- Market Talk

2025-08-04 20:25; UTC

Uždarbis

Transocean 2Q Loss $938M >RIG

2025-08-04 20:25; UTC

Uždarbis

Transocean 2Q Loss/Shr $1.06 >RIG

2025-08-04 20:18; UTC

Uždarbis

Palantir Stock Jumps. Earnings Blew Past Wall Street's Stratospheric Expectations. -- Barrons.com

2025-08-04 20:15; UTC

Uždarbis

Vertex Pharma: Guidance Includes Immaterial Cost Impact From Tariffs in 2025 Based on Currently Known Tariff Rates and Regulations >VRTX

2025-08-04 20:14; UTC

Uždarbis

Vertex Pharmaceuticals Reiterated FY25 Fincl Guidance >VRTX

2025-08-04 20:14; UTC

Uždarbis

Vertex Pharma: Mark Bunnage, D.Phil., SVP of Global Research, to Assume Role of CSO Effective Feb 1, 2026 >VRTX

2025-08-04 20:14; UTC

Uždarbis

Vertex Pharma: David Altshuler, Chief Scientific Officer, Intends to Retire Aug 1, 2026 >VRTX

2025-08-04 20:13; UTC

Uždarbis

Vertex Pharmaceuticals Backs FY25 Rev $11.85B-$12B >VRTX

2025-08-04 20:09; UTC

Uždarbis

Viper Energy: Initiating Avg Daily Production Guidance for 3Q of 46,000 to 49,000 Bo/d (86,000 to 92,000 Boe/d) >VNOM

2025-08-04 20:06; UTC

Uždarbis

Palantir Earnings Blow Past Wall Street's Stratospheric Expectations -- Barrons.com

2025-08-04 20:01; UTC

Uždarbis

Vertex Pharmaceuticals 2Q Net $1.03B >VRTX

2025-08-04 20:01; UTC

Uždarbis

Vertex Pharmaceuticals 2Q Adj EPS $4.52 >VRTX

2025-08-04 20:01; UTC

Uždarbis

Vertex Pharmaceuticals 2Q Rev $2.96B >VRTX

2025-08-04 20:01; UTC

Uždarbis

Vertex Pharmaceuticals 2Q EPS $3.99 >VRTX

2025-08-04 19:41; UTC

Rinkos pokalbiai

U.S. Natural Gas Futures Settle Lower -- Market Talk

2025-08-04 19:28; UTC

Rinkos pokalbiai

U.S. Hiring Expected to Recover Once Uncertainty Dissipates -- Market Talk

2025-08-04 19:07; UTC

Rinkos pokalbiai

Oil Extends Losing Streak As OPEC+ to Raise Output -- Market Talk

2025-08-04 18:27; UTC

Rinkos pokalbiai

Gold Climbs on Rate Cut Speculation -- Market Talk

Akcijų palyginimas

Kainos pokytis

Ultrapar Participacoes SA Prognozė

Kainos tikslas

By TipRanks

20.92% į viršų

12 mėnesių prognozė

Vidutinis 3.7 USD  20.92%

Aukščiausias 3.7 USD

Žemiausias 3.7 USD

Remiantis 1 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Ultrapar Participacoes SA kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Neutralu

1 ratings

0

Pirkti

1

Laikyti

0

Parduoti

Techninis įvertinimas

By Trading Central

N/A / 3.1341Palaikymas ir pasipriešinimas

Trumpalaikis periodas

Strong Bearish Evidence

Vidutinės trukmės periodas

Weak Bearish Evidence

Ilgalaikis periodas

Weak Bearish Evidence

Rinkos nuotaikos

By Acuity

49 / 145 reitingas Energijos sektorius

Naujienos nuotaikos

Bulių rinkos įrodymas

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Vidutinis

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Ultrapar Participacoes SA

Ultrapar Participações S.A., through its subsidiaries, operates in the energy and infrastructure business in Brazil. The company distributes liquefied petroleum gas to residential, commercial, and industrial consumers. It also operates Stella, a technology platform that connects renewable electric power generators and customers; and transports compressed natural gas. In addition, the company is involved in the distribution and marketing of gasoline, ethanol, diesel, fuel oil, kerosene, natural gas for vehicles, and lubricants; and holds AmPm convenience stores and provides Jet Oil lubricant services. Further, it operates liquid bulk storage terminals. Additionally, the company offers digital payments services, combining the abastece aí app and the loyalty program Km de Vantagens. It also exports its products and services to customers in Europe, the United States, Canada, other Latin American countries, Asia, and internationally. The company was founded in 1937 and is headquartered in São Paulo, Brazil.